News and Updates
News and Updates
NEWS AND UPDATES
Stay updated with the latest healthcare news
Kotak Pre-IPO fund to buy into diagnostic chain Neuberg
Kotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg's chairman, GSK Velu, plans to use the funds for acquisitions and expansion before a potential IPO next year. The diagnostics chain operates in multiple countries and processes millions of patient samples annually.
Milestone for India: Indigenous E-beam technology sterilises 50 lakh medical devices
To make the memory of this moment everlasting, RR-CAT Director Unmesh D Malshe presented a memento to Mohanty, the official added. According to the official, the facility to sterilize medical devices in this unit started in October 2022 and so far 50 lakh medical devices of different companies have been sterilized in it.
Agilus introduces Claudin 18.2 test for precise cancer diagnosis
The Claudin 18.2 test is a highly specialized diagnostic tool, offering precise identification of the Claudin 18.2 protein, a crucial biomarker for gastric, pancreatic, and other cancers. By providing precise identification of this biomarker, this test empowers oncologists with critical insights, aiding in the identification of patients eligible for targeted therapies, improving outcomes in cancer treatment, and fostering personalized medicine.
Ficci seeks govt nod to restart import of pre-owned expensive medical equipment
Industry chamber Ficci has urged the government to permit the import of pre-owned and refurbished high-end medical equipment. Previously facilitated with a no objection certificate, such imports have stalled since August 15 due to new registration requirements with the Central Drugs Standard Control Organization (CDSCO), which currently lacks provisions for refurbished equipment.
‘Early diagnosis key to fighting pancreatic cancer’
Dr Ramesh Ardhanari, senior consultant & head, department of surgery & surgical gastroenterology, said the five-year survival rate for pancreatic cancer remains staggeringly low at 12%. Around 1,200 people are diagnosed with this cancer every day worldwide, he said.
Beurer India Pvt Ltd launches GL 22 Blood Glucose Monitor
The GL 22 Blood Glucose Monitor, manufactured under the brand's 'Make in India' initiative, combines German precision with advanced technology designed to meet local needs. The device features comprehensive monitoring capabilities, including average readings for 7, 14, 30, and 90 days, offering crucial insights into blood glucose trends. These features closely align with HbA1c levels, a critical marker for long-term blood sugar control, ensuring users and healthcare providers can manage diabetes more effectively.
Suraksha Diagnostic is doing well, peers doing even better
The company is going to enhance revenues by forging more B2B corporate partnerships and increasing medical consultation services through polyclinic chambers at its diagnostic centres. It intends to expand beyond its core markets in adjacent geographies of eastern and north-eastern India. It will supplement organic growth with selective acquisitions.
'Low-quality' catheters supplied to West Bengal govt hospitals at high price, probe ordered
Low-quality catheters were also found in the stores of other hospitals, which indicates "possible involvement of insiders in the scam", a health department official said.
Molbio Diagnostics appoints Professor (Dr) Balram Bhargava, Dr Arun Kumar Jha as independent directors to its board
Professor (Dr) Bhargava is a leader in the public health sector with over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research, being at the forefront of managing several public health crises in India. Dr Kumar Jha brings a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance, and as an Economic Adviser in the Department of Health & Family Welfare, Ministry of Health & Family Welfare.
Medtronic launches FDA approved InterStim X sacral nerve stimulation therapy for bladder control, bowel control in India
Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to other non-invasive therapies. The system works by targeting nerve signals that regulate bladder functions, which may reduce symptoms of incontinence – such as frequent trips to the bathroom and accidents. Patients can try the InterStim X system with an evaluation phase before they decide to have the system implanted, and it's reversible if they change their sacral neuromodulation procedure is performed in two stages.
US EP diagnostic Catheter market set for 10% CAGR growth
Electrophysiology diagnostic catheters are used to detect and manage arrhythmias, irregular heart rhythms commonly associated with an ageing population and lifestyle factors such as hypertension, obesity, and physical inactivity.
Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat
Medical equipment makers such as Agilent are seeing soft demand from early-stage biotechs, as these smaller drug development companies remain cautious with investments even as recent rate cuts are expected to improve the funding environment for such clients.
HCG Teams Up with Trucan for cutting-edge cancer detection and therapy monitoring
These tests leverage advanced techniques, including next-generation sequencing and biomarker-driven diagnostics, to enable precise detection of primary, recurrent, and metastatic cancers, predict therapy response before treatment, and monitor patients undergoing chemotherapy or targeted therapy.
Musk's Neuralink to launch feasibility trial with brain implant, robotic arm
Neuralink is conducting its PRIME study, aimed at evaluating the safety of its wireless brain-computer interface and surgical robot. It is assessing the initial effect of the implant in patients with quadriplegia, a form of paralysis, to control external devices with their thoughts.
Singapore launches telehealth platform for diabetes management
Traditional diabetes management methods, such as glucose meters and insulin therapy, have notable limitations, including delayed treatment adjustments and a lack of real-time monitoring. These challenges contribute to less effective control of the condition.
MRI machine to be installed in Mandi hospital soon: Himachal CM
Chairing a review meeting with senior Congress leaders from Mandi district at Oakover, Shimla to discuss various developmental projects in the region, the chief minister emphasised the government's focus on improving facilities at the hospital, according to a statement.
Treatment, lab charges hiked 20% in govt medical college hospitals in Karnataka
The increased charges took effect recently in hospitals coming under the Bangalore Medical College and Research Institute (BMCRI) and various other autonomous medical education institutions elsewhere in the state. This was confirmed by Dr BL Sujatha Rathod, director of medical education.
J-K's Sher-e-Kashmir hospital to get LINAC for cancer treatment
"The health sector is a priority sector for the government and we are determined to provide world-class medical facilities to people here. This measure (LINAC procurement) has been taken in that direction and is one among many efforts the government has initiated for enhancing cancer treatment facilities across J&K," she said.
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.
Abbott introduces leadless pacemaker in India for patients with slow heart rhythms
"The AVEIR VR leadless pacemaker was designed to make the implantation and retrieval processes as seamless as possible for physicians and provide improvements over existing options," said Ajay Singh Chauhan, General Manager for Abbott's Cardiac Rhythm Management business in India, Southeast Asia, HK, Taiwan & Korea.
Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData
According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
Medical supplier Medline aims to raise over $5 billion in 2025 IPO, sources say
Northfield, Illinois-based Medline, which is owned by buyout firms Blackstone, Carlyle, and Hellman & Friedman, has invited several investment banks to pitch for lead roles on what is likely to be one of the marquee IPOs next year, the sources said, requesting anonymity as the discussions are confidential.
GMC to launch skull-base surgery unit
He said that the unit will function under the department of neurosurgery and the department of ear, nose, and throat (ENT). It will be led by consultant ENT surgeon at Bombay Hospital, Nishit Shah, and H N Reliance Mumbai, alongside head of the neurosurgery department at GMC, Ponraj Sundaram.
Warburg-backed Micro Life eyes $150 mn in pre-IPO round; eyes $5 bn valuation
Micro Life Sciences, India's largest medical devices group, is seeking to raise $150 million by selling a small stake, aiming for a $5 billion valuation. Backed by Warburg Pincus, the company plans to use the funds for expansion, including new manufacturing facilities and product launches.
Apollo Radiology International acquires UK-based InHealth Limited
ARI is projected to report over two million scans annually, spanning 24 countries and serving more than 200 healthcare organizations. Through this acquisition, ARI aims to expand its reporting services across a broader network of NHS partners in the UK.
IIT Indore develops technology to enhance safety of ECG machines, pacemakers; gets patent
According to the official, the new technology developed by the IIT Indore team is designed to create safe and secure chips for these ECG devices and pacemakers. It includes a crucial feature that distinguishes between genuine and counterfeit ECG detector chips before they are manufactured or integrated into devices.
Integrated diagnostics powered by genomics set to transform India’s healthcare landscape in the next 5-7 years
Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both communicable and non-communicable diseases. The integration of AI, machine learning, and affordable diagnostic platforms will play a key role in democratizing healthcare, ensuring access to high-quality diagnostic services even in Tier 3 cities. Collaborations with private and government insurance schemes, like Ayushman Bharat, will further propel this transformation, making genomic screening a part of primary healthcare.
Assam CM inaugurates new MRI machine at Guwahati Medical College and Hospital
Meanwhile, CM Sarma, who is also the BJP co-in-charge for Jharkhand elections, returned to Assam after carrying out the election campaign and posted on X, "Over the past four months, Jharkhand has truly felt like a second home to me. While I may have made a few adversaries during this period, they are far outnumbered by the friendships I've forged across this vibrant state."
Mumbai scientist wins top prize for rapid mpox testing kit
Dr Nandi was invited to Delhi to attend the annual Health Research Excellence Summit hosted by ICMR, where he was also recognised for his pioneering use of gene-editing technology to enhance polio safety protocols in research labs nationwide.
Medtronic lifts annual profit view on strong demand for medical devices
The Ireland-based company raised the lower end of its 2025 adjusted profit forecast to $5.44 per share from $5.42 earlier, keeping the upper end at $5.50. The new midpoint of $5.47 is slightly higher than analysts' estimates of $5.45, according to data compiled by LSEG.
Goan company invests $30mn in San Jose firm
The investment will accelerate OptraSCAN’s development of cutting-edge diagnostic testing equipment. “The strategic alliance with OptraSCAN is a significant step in our mission to make healthcare diagnostic devices accessible in India and beyond,” said Sriram Natarajan, chief executive officer of Molbio Diagnostics.
Air emergency in Delhi: Like pollution, face mask prices hit upper end
However, many people are using surgical masks, made ubiquitous by the Covid pandemic, because it is very affordable though they aren't effective in shielding people against respirable pollutants. Opposite AIIMS at Safdarjung Medicos, shopkeeper Javed said. "People are opting for cheaper surgical masks. We don't recommend its use, but it is cheaper," the shopkeeper said.
Surya Eye Hospital launches Oculus Myopia Master, diagnostic tool to track, manage myopia progression in children
Myopia Master uses a contactless, painless approach to measure critical eye parameters such as axial length, keratometry, and refraction, allowing for accurate monitoring and personalised treatment plans. By measuring key parameters of eye health and utilising a unique AI-based model for data analysis, it ensures personalised, effective care for every child, setting a new standard in myopia management.
Boston Scientific launches multi-functional imaging system AVVIGO
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS vessel images during percutaneous coronary intervention (PCI) procedures.
Molbio Diagnostics invests $30 million in OptraSCAN
In addition to improved access to diagnostic tools, this collaboration will support AI-driven pathology solutions that aim to empower healthcare professionals to diagnose diseases more efficiently, leading to better patient outcomes. With this partnership, OptraSCAN can expand its product portfolio and increase availability, making life-saving diagnostic technology accessible to facilities in rural and under-resourced regions in India.
Poly Medicure joins zero emission maritime buyers alliance
The ZEMBA tender aims to aggregate over 80 billion tonne-nautical miles of demand for zero-emission shipping and is set to introduce e-fuel-powered container shipping at scale by 2027.
Mindray's troponin I assay safely rules out heart attacks early: US researchers
Unusually precise measurements of cardiac troponin I made possible using the Mindray assay, meant additional individuals could also be ruled out. In total, across all cardiac troponin I measures, researchers were able to identify 60 per cent of patients presenting to the emergency department with heart attack like symptoms, who could be safely sent home.
Lubrizol and Polyhose to set up medical tubes manufacturing unit in Chennai
The proposed manufacturing facility will be operational by 2026 and will increase Lubrizol’s local medical tubing volume five-fold.These tubes will be used in neurovascular and cardiovascular medical applications, such as balloon catheters and minimally invasive procedure catheters.
India: On the Verge of Becoming the Diabetes Capital of the World
Diabetes is a silent killer—early detection is the only way to win the battle.Taking control of your sugar today means fewer complications tomorrow.A healthy lifestyle is the sweetest gift you can give yourself and your family.Each one of us has the power to prevent diabetes from taking over our lives or loved ones'.
Transforming Surgery: Yashoda Group partners with Medtronic for robotic-assisted systems
Robotic surgery, with its advantages over conventional open and laparoscopic surgeries—such as faster recovery times, reduced blood loss, lower infection risks, shorter hospital stays, and the ability to perform highly complex procedures—is fast becoming essential.
NEWS AND UPDATES
Stay updated with the latest healthcare news
Kotak Pre-IPO fund to buy into diagnostic chain Neuberg
Kotak Pre IPO Opportunities Fund is in advanced talks to acquire a 15% stake in Neuberg Diagnostics for approximately Rs 450 crore. Neuberg's chairman, GSK Velu, plans to use the funds for acquisitions and expansion before a potential IPO next year. The diagnostics chain operates in multiple countries and processes millions of patient samples annually.
Milestone for India: Indigenous E-beam technology sterilises 50 lakh medical devices
To make the memory of this moment everlasting, RR-CAT Director Unmesh D Malshe presented a memento to Mohanty, the official added. According to the official, the facility to sterilize medical devices in this unit started in October 2022 and so far 50 lakh medical devices of different companies have been sterilized in it.
Agilus introduces Claudin 18.2 test for precise cancer diagnosis
The Claudin 18.2 test is a highly specialized diagnostic tool, offering precise identification of the Claudin 18.2 protein, a crucial biomarker for gastric, pancreatic, and other cancers. By providing precise identification of this biomarker, this test empowers oncologists with critical insights, aiding in the identification of patients eligible for targeted therapies, improving outcomes in cancer treatment, and fostering personalized medicine.
Ficci seeks govt nod to restart import of pre-owned expensive medical equipment
Industry chamber Ficci has urged the government to permit the import of pre-owned and refurbished high-end medical equipment. Previously facilitated with a no objection certificate, such imports have stalled since August 15 due to new registration requirements with the Central Drugs Standard Control Organization (CDSCO), which currently lacks provisions for refurbished equipment.
‘Early diagnosis key to fighting pancreatic cancer’
Dr Ramesh Ardhanari, senior consultant & head, department of surgery & surgical gastroenterology, said the five-year survival rate for pancreatic cancer remains staggeringly low at 12%. Around 1,200 people are diagnosed with this cancer every day worldwide, he said.
Beurer India Pvt Ltd launches GL 22 Blood Glucose Monitor
The GL 22 Blood Glucose Monitor, manufactured under the brand's 'Make in India' initiative, combines German precision with advanced technology designed to meet local needs. The device features comprehensive monitoring capabilities, including average readings for 7, 14, 30, and 90 days, offering crucial insights into blood glucose trends. These features closely align with HbA1c levels, a critical marker for long-term blood sugar control, ensuring users and healthcare providers can manage diabetes more effectively.
Suraksha Diagnostic is doing well, peers doing even better
The company is going to enhance revenues by forging more B2B corporate partnerships and increasing medical consultation services through polyclinic chambers at its diagnostic centres. It intends to expand beyond its core markets in adjacent geographies of eastern and north-eastern India. It will supplement organic growth with selective acquisitions.
'Low-quality' catheters supplied to West Bengal govt hospitals at high price, probe ordered
Low-quality catheters were also found in the stores of other hospitals, which indicates "possible involvement of insiders in the scam", a health department official said.
Molbio Diagnostics appoints Professor (Dr) Balram Bhargava, Dr Arun Kumar Jha as independent directors to its board
Professor (Dr) Bhargava is a leader in the public health sector with over 35 years of experience in medical research and health system strengthening. His previous roles include Director-General of the Indian Council of Medical Research and Secretary of India’s Department of Health Research, being at the forefront of managing several public health crises in India. Dr Kumar Jha brings a wealth of experience in public health and policy, including his role as an Adviser in the Department of Economic Affairs, Ministry of Finance, and as an Economic Adviser in the Department of Health & Family Welfare, Ministry of Health & Family Welfare.
Medtronic launches FDA approved InterStim X sacral nerve stimulation therapy for bladder control, bowel control in India
Sacral neuromodulation is an advanced therapy for people with bladder and bowel control issues that are not responding to other non-invasive therapies. The system works by targeting nerve signals that regulate bladder functions, which may reduce symptoms of incontinence – such as frequent trips to the bathroom and accidents. Patients can try the InterStim X system with an evaluation phase before they decide to have the system implanted, and it's reversible if they change their sacral neuromodulation procedure is performed in two stages.
US EP diagnostic Catheter market set for 10% CAGR growth
Electrophysiology diagnostic catheters are used to detect and manage arrhythmias, irregular heart rhythms commonly associated with an ageing population and lifestyle factors such as hypertension, obesity, and physical inactivity.
Medical equipment maker Agilent's downbeat annual forecast clouds fourth-quarter beat
Medical equipment makers such as Agilent are seeing soft demand from early-stage biotechs, as these smaller drug development companies remain cautious with investments even as recent rate cuts are expected to improve the funding environment for such clients.
HCG Teams Up with Trucan for cutting-edge cancer detection and therapy monitoring
These tests leverage advanced techniques, including next-generation sequencing and biomarker-driven diagnostics, to enable precise detection of primary, recurrent, and metastatic cancers, predict therapy response before treatment, and monitor patients undergoing chemotherapy or targeted therapy.
Musk's Neuralink to launch feasibility trial with brain implant, robotic arm
Neuralink is conducting its PRIME study, aimed at evaluating the safety of its wireless brain-computer interface and surgical robot. It is assessing the initial effect of the implant in patients with quadriplegia, a form of paralysis, to control external devices with their thoughts.
Singapore launches telehealth platform for diabetes management
Traditional diabetes management methods, such as glucose meters and insulin therapy, have notable limitations, including delayed treatment adjustments and a lack of real-time monitoring. These challenges contribute to less effective control of the condition.
MRI machine to be installed in Mandi hospital soon: Himachal CM
Chairing a review meeting with senior Congress leaders from Mandi district at Oakover, Shimla to discuss various developmental projects in the region, the chief minister emphasised the government's focus on improving facilities at the hospital, according to a statement.
Treatment, lab charges hiked 20% in govt medical college hospitals in Karnataka
The increased charges took effect recently in hospitals coming under the Bangalore Medical College and Research Institute (BMCRI) and various other autonomous medical education institutions elsewhere in the state. This was confirmed by Dr BL Sujatha Rathod, director of medical education.
J-K's Sher-e-Kashmir hospital to get LINAC for cancer treatment
"The health sector is a priority sector for the government and we are determined to provide world-class medical facilities to people here. This measure (LINAC procurement) has been taken in that direction and is one among many efforts the government has initiated for enhancing cancer treatment facilities across J&K," she said.
Cinven secures Italian nod to sell minority stake in Synlab to Labcorp
Golden powers legislation requires Italian government approval for any decision which results in changes in the ownership, control or availability of strategic assets in the country.
Abbott introduces leadless pacemaker in India for patients with slow heart rhythms
"The AVEIR VR leadless pacemaker was designed to make the implantation and retrieval processes as seamless as possible for physicians and provide improvements over existing options," said Ajay Singh Chauhan, General Manager for Abbott's Cardiac Rhythm Management business in India, Southeast Asia, HK, Taiwan & Korea.
Diagnosed prevalent cases of type 1 diabetes to reach 3.166 mn in 2033: GlobalData
According to GlobalData epidemiologists, the US had the highest number of diagnosed prevalent cases of T1D in 2023 with 1.77 million in 2023, whereas Japan had the lowest number of prevalent cases at 120,000.
Medical supplier Medline aims to raise over $5 billion in 2025 IPO, sources say
Northfield, Illinois-based Medline, which is owned by buyout firms Blackstone, Carlyle, and Hellman & Friedman, has invited several investment banks to pitch for lead roles on what is likely to be one of the marquee IPOs next year, the sources said, requesting anonymity as the discussions are confidential.
GMC to launch skull-base surgery unit
He said that the unit will function under the department of neurosurgery and the department of ear, nose, and throat (ENT). It will be led by consultant ENT surgeon at Bombay Hospital, Nishit Shah, and H N Reliance Mumbai, alongside head of the neurosurgery department at GMC, Ponraj Sundaram.
Warburg-backed Micro Life eyes $150 mn in pre-IPO round; eyes $5 bn valuation
Micro Life Sciences, India's largest medical devices group, is seeking to raise $150 million by selling a small stake, aiming for a $5 billion valuation. Backed by Warburg Pincus, the company plans to use the funds for expansion, including new manufacturing facilities and product launches.
Apollo Radiology International acquires UK-based InHealth Limited
ARI is projected to report over two million scans annually, spanning 24 countries and serving more than 200 healthcare organizations. Through this acquisition, ARI aims to expand its reporting services across a broader network of NHS partners in the UK.
IIT Indore develops technology to enhance safety of ECG machines, pacemakers; gets patent
According to the official, the new technology developed by the IIT Indore team is designed to create safe and secure chips for these ECG devices and pacemakers. It includes a crucial feature that distinguishes between genuine and counterfeit ECG detector chips before they are manufactured or integrated into devices.
Integrated diagnostics powered by genomics set to transform India’s healthcare landscape in the next 5-7 years
Genomic tests, now becoming as routine as pathology and imaging, are poised to enhance early detection of both communicable and non-communicable diseases. The integration of AI, machine learning, and affordable diagnostic platforms will play a key role in democratizing healthcare, ensuring access to high-quality diagnostic services even in Tier 3 cities. Collaborations with private and government insurance schemes, like Ayushman Bharat, will further propel this transformation, making genomic screening a part of primary healthcare.
Assam CM inaugurates new MRI machine at Guwahati Medical College and Hospital
Meanwhile, CM Sarma, who is also the BJP co-in-charge for Jharkhand elections, returned to Assam after carrying out the election campaign and posted on X, "Over the past four months, Jharkhand has truly felt like a second home to me. While I may have made a few adversaries during this period, they are far outnumbered by the friendships I've forged across this vibrant state."
Mumbai scientist wins top prize for rapid mpox testing kit
Dr Nandi was invited to Delhi to attend the annual Health Research Excellence Summit hosted by ICMR, where he was also recognised for his pioneering use of gene-editing technology to enhance polio safety protocols in research labs nationwide.
Medtronic lifts annual profit view on strong demand for medical devices
The Ireland-based company raised the lower end of its 2025 adjusted profit forecast to $5.44 per share from $5.42 earlier, keeping the upper end at $5.50. The new midpoint of $5.47 is slightly higher than analysts' estimates of $5.45, according to data compiled by LSEG.
Goan company invests $30mn in San Jose firm
The investment will accelerate OptraSCAN’s development of cutting-edge diagnostic testing equipment. “The strategic alliance with OptraSCAN is a significant step in our mission to make healthcare diagnostic devices accessible in India and beyond,” said Sriram Natarajan, chief executive officer of Molbio Diagnostics.
Air emergency in Delhi: Like pollution, face mask prices hit upper end
However, many people are using surgical masks, made ubiquitous by the Covid pandemic, because it is very affordable though they aren't effective in shielding people against respirable pollutants. Opposite AIIMS at Safdarjung Medicos, shopkeeper Javed said. "People are opting for cheaper surgical masks. We don't recommend its use, but it is cheaper," the shopkeeper said.
Surya Eye Hospital launches Oculus Myopia Master, diagnostic tool to track, manage myopia progression in children
Myopia Master uses a contactless, painless approach to measure critical eye parameters such as axial length, keratometry, and refraction, allowing for accurate monitoring and personalised treatment plans. By measuring key parameters of eye health and utilising a unique AI-based model for data analysis, it ensures personalised, effective care for every child, setting a new standard in myopia management.
Boston Scientific launches multi-functional imaging system AVVIGO
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS vessel images during percutaneous coronary intervention (PCI) procedures.
Molbio Diagnostics invests $30 million in OptraSCAN
In addition to improved access to diagnostic tools, this collaboration will support AI-driven pathology solutions that aim to empower healthcare professionals to diagnose diseases more efficiently, leading to better patient outcomes. With this partnership, OptraSCAN can expand its product portfolio and increase availability, making life-saving diagnostic technology accessible to facilities in rural and under-resourced regions in India.
Poly Medicure joins zero emission maritime buyers alliance
The ZEMBA tender aims to aggregate over 80 billion tonne-nautical miles of demand for zero-emission shipping and is set to introduce e-fuel-powered container shipping at scale by 2027.
Mindray's troponin I assay safely rules out heart attacks early: US researchers
Unusually precise measurements of cardiac troponin I made possible using the Mindray assay, meant additional individuals could also be ruled out. In total, across all cardiac troponin I measures, researchers were able to identify 60 per cent of patients presenting to the emergency department with heart attack like symptoms, who could be safely sent home.
Lubrizol and Polyhose to set up medical tubes manufacturing unit in Chennai
The proposed manufacturing facility will be operational by 2026 and will increase Lubrizol’s local medical tubing volume five-fold.These tubes will be used in neurovascular and cardiovascular medical applications, such as balloon catheters and minimally invasive procedure catheters.
India: On the Verge of Becoming the Diabetes Capital of the World
Diabetes is a silent killer—early detection is the only way to win the battle.Taking control of your sugar today means fewer complications tomorrow.A healthy lifestyle is the sweetest gift you can give yourself and your family.Each one of us has the power to prevent diabetes from taking over our lives or loved ones'.
Transforming Surgery: Yashoda Group partners with Medtronic for robotic-assisted systems
Robotic surgery, with its advantages over conventional open and laparoscopic surgeries—such as faster recovery times, reduced blood loss, lower infection risks, shorter hospital stays, and the ability to perform highly complex procedures—is fast becoming essential.